Patents Assigned to Intellipharmaceutics Corp
  • Pharmaceutical composition having reduced abuse potential
    Patent number: 10632205
    Abstract: A pharmaceutical paste composition comprising an active ingredient such as an addictive substance, a controlled release agent, and a pharmaceutically suitable aqueous or non-aqueous carrier. The composition may comprise one or more of a clay, or an oily, waxy, or fatty substance. The composition may be filled into a capsule or other dispensing device. The composition may reduce dose dumping of an active ingredient. Methods of making and using the composition are also described.
    Type: Grant
    Filed: May 29, 2015
    Date of Patent: April 28, 2020
    Assignee: INTELLIPHARMACEUTICS CORP
    Inventors: Isa Odidi, Amina Odidi
  • Controlled release composition using transition coating, and method of preparing same
    Patent number: 10624858
    Abstract: The present invention is concerned with the use of transition coating and transition coating composition to control and or target the release of active pharmaceutical ingredients, and biological, chemical, neutraceutical, agricultural and nutritional materials and a method of preparing controlled release systems utilizing these components.
    Type: Grant
    Filed: August 23, 2004
    Date of Patent: April 21, 2020
    Assignee: INTELLIPHARMACEUTICS CORP
    Inventors: Isa Odidi, Amina Odidi
  • PROTON PUMP-INHIBITOR-CONTAINING CAPSULES WHICH COMPRISE SUBUNITS DIFFERENTLY STRUCTURED FOR A DELAYED RELEASE OF THE ACTIVE INGREDIENT
    Publication number: 20140322312
    Abstract: An oral pharmaceutical composition comprises multiple populations of at least one of beads, pellets, tablets and granules provided in a capsule, the composition comprising: a first population of a pharmaceutical active comprising a pharmaceutical active substance releasable at a first rate; a population of a basic substance; and a second population of a pharmaceutical active comprising a pharmaceutical active substance releasable at a second rate. In another embodiment, the oral pharmaceutical composition comprises multiple populations of at least one of beads, pellets, tablets and granules provided in a capsule, the composition comprising: a population of a pharmaceutical active; a population of a basic substance; a population of enteric coated pharmaceutical active; and a population of enteric coated basic substance. The composition can provide multiple site specific delivery of a pharmaceutical active in a rapid, delayed and/or sustained release manner into the plasma.
    Type: Application
    Filed: July 10, 2014
    Publication date: October 30, 2014
    Applicant: INTELLIPHARMACEUTICS CORP
    Inventors: Isa Odidi, Amina Odidi
  • Controlled release formulation containing bupropion
    Patent number: 6652882
    Abstract: The present invention relates to a controlled release pharmaceutical formulation comprising an effective amount of an active ingredient and from about 1% to about 70% by weight of an uncrosslinked polymer, a crosslinked insoluble polymer or a mixture of uncrosslinked and crosslinked polymers.
    Type: Grant
    Filed: October 5, 1998
    Date of Patent: November 25, 2003
    Assignee: Intellipharmaceutics Corp
    Inventors: Isa Odidi, Amina Odidi